How to Cite
Abstract
Metabolic syndrome has been associated with the incidence of liver and chronic kidney damage. This study aimed at exploring the mitigatory action of Dissotis rotundifolia whole plant extract on metabolic syndrome-induced hepato-renal dysfunctions. Fifty (50) adult male Wistar rats weighing between 150-180 g were randomly distributed into groups of ten rats each as follows: Group 1 (Control), Group 2 (MetS control), Group 3 (MetS + 100 mg/kg ethanol extract of Dissotis rotundifolia), Group 4 (MetS + 200 mg/kg ethanol extract of Dissotis rotundifolia), and Group 5 (MetS + 20 mg/kg Rosuvastatin). Metabolic syndrome was established by feeding the rats with high carbohydrate (10 -20% fructose) in drinking water and high fat-induced diet (20 - 40%) for 8 weeks. Biomarkers of hepatic and renal damage, oxidative stress, antioxidant parameters, lipid profiles, and immunohistochemistry of the liver and kidney tissues of rats were determined. The results showed that metabolic syndrome caused a significant increase in biomarkers of oxidative stress malondialdehyde (MDA), hydrogen peroxide (H2O2) generation, Low Density Lipoprotein cholesterol (LDL-c), High Density Lipoprotein cholesterol (HDL-c), Triglycerides (TG), Total Cholesterol (TC), but significantly reduced hepatic and renal glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione S-transferase (GST) in comparison with the control. Furthermore, biomarkers of renal and hepatic damage were significantly elevated in MetS untreated rats. Higher renal immune-reactivity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) but lower expression of Angiotensin Converting Enzyme (ACE) was recorded for MetS untreated rats. Dissotis rotundifolia extractmitigated biomarkers of oxidative stress, hepato-renal dysfunctions, and improved antioxidant defense system. The observed protective effects of Dissotis rotundifolia on metabolic syndrome-induced hepatic and renal damage could be due to amelioration of lipid peroxidation and increased antioxidant defense system.
References
Adinortey, M.B., Ansah, C., Aboagye, B., Sarfo, J.K., Martey, O. and Nyarko, A.K. (2020). Flavonoid-Rich Extract of Dissotis rotundifolia Whole Plant Protects against Ethanol-Induced Gastric Mucosal Damage. Biochem. Res. Int. 2020:7656127.
Alexander, M.P., Patel, T.V., Farag, Y.M, Florez, A., Rennke, H.G. and Singh, A.K. (2009). Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am. J. Kid. Dis. 53:751–9.
Barrios-Ramos, J., Garduño-Siciliano, L., Loredo-Mendoza, M., Chamorro-Cevallos, G. and Jaramillo-Flores, M., 2014. A quick model for the induction of metabolic syndrome markers in rats. Intern. Med. 4:1-5.
Beutler, E. and Kelly, B.M. (1963). The effect of sodium nitrite on red cell GSH. Experientia. 19(2): 96-97.
Bruno, R. and Ghiadoni, L. (2018). Polyphenols, Antioxidants, and the Sympathetic Nervous System. Curr. Pharm. Des. 24:130.
Cai, L., Liu, S., Sun, L., Wang, Y., Ji, H. and Li, J. (2015). Application of tea polyphenols in combination with 6-gingerol on shrimp paste of during storage: Biogenic amines formation and quality determination. Front. Microbiol. 981.
Carrier, A. (2017). Metabolic Syndrome and Oxidative Stress: A Complex Relationship. Antioxid. Redox Signal. 26(9), 429–431.
Casas, R., Sacanella, E. and Estruch R. (2014). The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr. Metab. Immune Disord. Drug Targets. 14(4):245-54.
Castro-Quezada, I., Román-Viñas, B. and Serra-Majem, L. (2014). The Mediterranean diet and nutritional adequacy: a review. Nutrients. 6(1):231-48.
Darkwah, W. K., Ao, Y., Adinortey, M. B., Weremfo, A., Abrokwah, F. K., and Afriyie, E. (2018). Total Phenolic, Flavonoid and Alkaloid Contents, Oxidative DNA Damage Protective and Antioxidant Properties of Methanol and Aqueous Extracts of Dissotis rotundifolia Whole Plant. Free Radicals and Antioxidants. 8(2): 82–88.
Das, D., Shruthi, N.R., Banerjee, A., Jothimani, G., Duttaroy, A.K. and Pathak, S. (2023). Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies. Front. Nutr. 10:1221438.
Djehoue, R., AbdouMadjid, O. A., Sanni, A. and Lagnika, L. (2020). Phytochemical composition and antioxidant property of Dissotis rotundifolia used for malaria management in south Benin. J. Med. Plants Stud. 8(2): 23-29.
Ezeabara, C.A., Ezema, C.M. and Anyanele, W.C. 2022. Phytochemical and Proximate Determinations of Dissotis rotundifolia (Sm.) Triana Leaf. Int. J. Sci. Res. Multidiscip. 8, (11): 47-53.
Fallavena, L.P., Rodrigues, N.P., Marczak, L.D.F., and Mercali GD. Formation of advanced glycation end products by novel food processing technologies: a review. Food Chem. 133338.
Fortuno, A., San Jose, G., Moreno, M.U., Beloqui, O., Diez, J. and Zalba, G. (2006). Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes. 55:209–15.
Gbadamosi, I. T., Opatola, D. G., Oyagbemi, A. A., Aiibade, T. O., Bolaji-Alabi, F. B., Omobowale, T. O., Saba, A. B., Adedapo, A. A., Yakubu, M. A. and Oguntibeju, O. O. (2020). Methanol extract of Caesalpinia benthamiana normalises blood pressure and attenuates oxidative stress in uninephrectomized hyperthensive rats. J. Basic Clin. Physiol. Pharmacol. 32(2): 109 – 119.
Gill LS (1992). Ethnomedical uses of plants in Nigeria. University of Benin press, Nigeria, pp 103.
Gornall, A.G., Bardawill, C.J. and David, M.M. (1949). Determination of serum proteins by means of the biuret reaction. J. biol. Chem, 177(2): 751-766.
Gouveia, H.J.C.B., Urquiza-Martínez, M.V., Manhães-de-Castro, R., Costa-de-Santana, B.J.R., Villarreal, J.P., Mercado-Camargo, R., Torner, L., de Souza A.J., Toscano, A.E. and Guzmán-Quevedo, O. 2022. Effects of the Treatment with Flavonoids on Metabolic Syndrome Components in Humans: A Systematic Review Focusing on Mechanisms of Action. Int. J. Mol. Sci. 23(15):8344.
Grabner, G.F., Xie, H., Schweiger, M., Zechner, R. (2021). Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab 3, 1445–1465.
Graf, B.L., Raskin, I., Cefalu, W.T., Ribnicky, D.M. (2010). Plant-derived therapeutics for the treatment of metabolic syndrome. Curr. Opin. Investig. Drugs. 11(10):1107-15.
Grandl, G. and Wolfrum, C. (2018). Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin. Immunopathol. 40:215–224.
Grupper, A., Rabinowich, A., BenShabat, I., Tzadok, R., Schwartz, D., Schwartz, I.F., Goykhman, Y., Kliuk, B.O., Baruch, R., Shashar, M., Cohen-Hagai, K. and Katchman, H. (2022). Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes. Am. J. Nephrol. 53:636-645.
Habig, W.H., 1974. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139.
He, L., Xing, Y., Ren, X., Zheng, M., Yu, S., Wang, Y., Xiu, Z. and Dong, Y. (2022). Mulberry Leaf Extract Improves Metabolic Syndrome by Alleviating Lipid Accumulation In Vitro and In Vivo. Molecules. 27(16):5111.
James, A. M., Collins, Y., Logan, A. and Murphy, M. P. (2012). Mitochondrial oxidative stress, and the metabolic syndrome. Trends Endocrinol. Metab. 23: 429–434.
Jollow, D.J., Mitchell, J.R., Zampaglione, N.A. and Gillette, J.R., 1974. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology, 11(3): 151-169.
Kathak, R.R., Sumon, A.H., Molla, N.H., Hasan, M., Miah, R., Tuba, H.R., Habib, A. and Ali, N. (2022).The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Sci. Rep. 12:1711.
Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., Kikuchi, A. (2019). Metabolic Syndrome is a Predictor of Decreased Renal Function Among Community-Dwelling Middle-Aged and Elderly Japanese. Int. Urol. Nephrol.12:2285–94.
Kayali, R., Çakatay, U., Akçay, T. and Altuğ, T. (2006). Effect of alpha‐lipoic acid supplementation on markers of protein oxidation in post‐mitotic tissues of ageing rat. Cell Biochem. Funct. 24(1): 79-85.
Kazancioğlu, R. (2013). Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 3(4):368-371.
Kohli, R., Kirby, M., Xanthakos, S.A., Softic, S., Feldstein, A.E., Saxena, V., Tang, P.H., Miles, L., Miles, M.V., Balistreri, W.F. and Woods, S.C., 2010. High‐fructose, medium chain trans-fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 52(3):934-944.
Korac, B., Kalezic, A., Pekovic-Vaughan, V., Korac. A. and Jankovic A. (2021). Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol. 42:101887.
Kotronen, A. and Yki-Järvinen, H. (2007). Liver fat in the metabolic syndrome. J. Clin. Endocrinol. Metab. 92: 3490-3497.
Kwitek, A.E. (2019). Rat Models of Metabolic Syndrome. Methods Mol Biol. 2018:269-285.
Lasker, S., Rahman, M.M., Parvez, F., Zamila, M., Miah, P., Nahar, K., Kabir, F., Sharmin, S.B., Subhan, N., Ahsan, G.U. and Alam, M.A. (2019). High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation. Sci. Rep. 9: 20026.
Li, Y., Yang, H., Nong, H., Wang, F., Wang, Y., Xu, Y., Zhang, J., Zhao, H., Cao, Z., Yang, Q. and Li, J. (2023). 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR) protects hair cells from cisplatin-induced ototoxicity in vitro: possible relation to the activities of p38 MAPK signaling pathway. Arch Toxicol. 2023 Aug 22.
Lin, F.A., Hwang, L.C., Tsou, M.T. and Huang, W.H. (2023). Incidence of Metabolic Syndrome and Its Risk Factors in Elderly with Nonalcoholic Fatty Liver Disease. Diabetes Metab. Syndr. Obes. 6:2835-2842.
Luo, Z., Xu, W., Zhang, Y., Di, L. and Shan, J. (2020). A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota. Pharmacol. Res. 160:105088.
Mahmoud, A.A. and Elshazly, S.M. (2014). Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One. 9(9): e106993.
Misra, H.P. and Fridovich, I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247(10): 3170-3175.
Monserrat-Mesquida, M., Quetglas-Llabrés, M., Capó, X., Bouzas, C., Mateos, D., Pons, A., Tur, J.A. and Sureda, A. (2020). Metabolic Syndrome Is Associated with Oxidative Stress and Proinflammatory State. Antioxidants. 9(3):236.
Olaleye, S.B., Adaramoye, O.A., Erigbali, P.P. and Adeniyi, O.S. 2007. Lead exposure increases oxidative stress in the gastric mucosa of HCl/ethanol-exposed rats. World Journal of Gastroenterology: WJG, 13(38): 5121.
Oyagbemi, A.A., Ajibade, T.O., Esan, O.O., Adetona, M.O., Obisesan, A.D., Adeogun, A.V., Awoyomi, O.V., Badejo, J.A., Adedapo, A.D.A., Omobowale, T.O., Olaleye, O.I., Ola-Davies, O.E., Saba, A.B., Adedapo, A.A., Nkadimeng, S.M., McGaw, L.J., Kayoka-Kabongo, P.N., Yakubu, M.A., Nwulia, E. and Oguntibeju, O.O. (2023)Naringin abrogates angiotensin-converting enzyme (ACE) activity and podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension. Biomarkers. 28(2):206-216.
Oyagbemi, A.A., Omobowale, T.O., Asenuga, E.R., Adejumobi, A.O., Ajibade, T.O., Ige, T.M., Ogunpolu, B.S., Adedapo, A.A. and Yakubu, M.A., 2017. Sodium fluoride induces hypertension and cardiac complications through generation of reactive oxygen species and activation of nuclear factor kappa beta. Environ. Toxicol. 32(4): 1089-1101.
Oyagbemi, A.A., Omobowale, T.O., Awoyomi, O.V., Ajibade, T.O., Falayi, O.O., Ogunpolu, B.S., Okotie, U.J., Asenuga, E.R., Adejumobi, O.A., Hassan, F.O. and Ola-Davies, O.E., (2019). Cobalt chloride toxicity elicited hypertension and cardiac complication via induction of oxidative stress and upregulation of COX-2/Bax signaling pathway. Hum Exp Toxicology, 38(5): 519-532.
Oyagbemi, A.A., Omobowale, T.O., Ola‐Davies, O.E., Asenuga, E.R., Ajibade, T.O., Adejumobi, O.A., Arojojoye, O.A., Afolabi, J.M., Ogunpolu, B.S., Falayi, O.O. and Hassan, F.O., 2018. Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways. Biofactors, 44(5): 465-479.
Palladini, G., Di Pasqua, L.G., Berardo, C., Siciliano, V., Richelmi, P., Mannucci, B., Croce, A.C., Rizzo, V., Perlini, S., Vairetti, M. and Ferrigno A. (2019). Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress versus Metalloproteinases. Nutrients. 11:799.
Panday, A., Sahoo, M., Osorio, D. and Batra, S. (2015). NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell. Mol. Immunol. 12: 5–23.
Perdomo, C.M., Frühbeck, G. and Escalada, J. (2019). Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients. 11:677.
Rani, V., Gagan, D., Rakesh, K. S., Komaraiah, P. and Umesh, C.S.Y (2016). Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 148: 183-193.
Rath, G., Toure, ́ A., Nianga, M., Wolfender, J. L., and Hostettmann, K. (1995). Characterization of C-glycosylflavones from Dissotis rotundifolia by liquid chromatography—UV diode array detection—tandem mass spectrometry. Chromatographia. 41 (5-6): 332–342.
Rector, R.S., Thyfault, J.P., Wei, Y, Ibdah and J.A.. (2008). Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol, 14 (2008), pp. 185-192.
Rivadeneyra-Domínguez, E., Becerra-Contreras, Y., Vázquez-Luna, A., Díaz-Sobac, R. and Rodríguez-Landa, J.F. (2018). Alterations of blood chemistry, hepatic and renal function, and blood cytometry in acrylamide-treated rats. Toxicol Rep. 2018 Nov 6;5:1124-1128.
Rochlani, Y., Pothineni, N.V., Kovelamudi, S. and Mehta, J.L. (2017 ). Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther. Adv. Cardiovasc. Dis. 11(8):215-225.
Rochlani, Y., Pothineni, N.V., Kovelamudi, S., Mehta, J.L. (2017). Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther. Adv. Cardiovasc. Dis. 11:215–25.
Rodríguez-Correa, E., González-Pérez, I., Clavel-Pérez, P.I., Contreras-Vargas, Y. and Carvajal, K. (2020). Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: what is the best choice? Nutr. Diabetes 10: 24.
Romejko, K., Markowska, M. and Niemczyk, S. (2023). The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int. J. Mol. Sci. 24(13):10470.
Saklayen, M.G. (2018). The Global Epidemic of the Metabolic Syndrome. Curr. Hyperten. Rep. 20 (2):12.
Sanyal, D. Mukherjee, P., Raychaudhuri, M., Ghosh, S., Mukherjee, S. and Chowdhury, S. (2015). Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J. Endocrinol. Metab. 19, 597–601.
Scurt, F.G., Ganz, M.J., Herzog, C., Bose, K., Mertens, P.R. and Chatzikyrkou C. (2024). Association of metabolic syndrome and chronic kidney disease. Obes. Rev. 25(1):e13649.
Soleimani, M., Barone, S., Luo, H. and Zahedi, K. (2023). Pathogenesis of Hypertension in Metabolic Syndrome: The Role of Fructose and Salt. Int. J. Mol. Sci. 24(5):4294.
Spahis, S., Borys, J. M. and Levy, E. (2017). Metabolic syndrome as a multifaceted risk factor for oxidative stress. Antiox. Redox Signal. 26 (9): 445–461.
Stanciu, S., Rusu, E., Miricescu, D., Radu, A.C., Axinia, B., Vrabie, A.M., Ionescu, R., Jinga, M. and Sirbu, C.A. (2023). Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. Metabolites. 13(1):87.
Thomas, G., Sehgal, A.R., Kashyap, S.R., Srinivas, T.R., Kirwan, J.P. and Navaneethan, S.D. (2011). Metabolic syndrome, and kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 6: 2364-2373.
Varshney, R. and Kale, R.K., 1990. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Inter J. Rad Biol. 58(5): 733-743.
Voth, M., Verboket, R., Henrich, D. and Marzi, I. (2023). L-FABP and NGAL are novel biomarkers for detection of abdominal injury and hemorrhagic shock. Injury. 54(5):1246-1256.
Wang, J., Li, X., Han, X., Yang, K., Liu, B., Li, Y., Peipei, W., Xuezhen, L., Kuai, Y., Xiayun, D., Yuan, J., Yao, P., Zhang, X., Huan, G., Youjie, W., Weihong, C., Sheng, W., Miao, X., Xinwen, M., Liang, Y., Handong, Y., Hu, F., Tangchun, W. and He, M. (2015). Serum creatinine levels and risk of metabolic syndrome in a middle-aged and older Chinese population. Clin. Chim. Acta. 440:177-82.
Wang, TY., Wang, RF., Bu, ZY., Targher, G., Byrne, C.D., Sun, D.Q. and Zheng, M.H. (2022). Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat. Rev. Nephrol. 18: 259–268.
Wolff, S.P. (1994). Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233:182–189.
Yang, M., Liu, S. and Zhang, C. (2022). The Related Metabolic Diseases and Treatments of Obesity. Healthcare. 10(9):1616.
Yewale, R., V., Ramakrishna, B.S., Venugopal, G., Doraiswami, B.V. and Rajini, K. (2023). Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study. Indian J Gastroenterol. 42(1):106-117.
Zhang, S., Xu, M., Zhang, W., Liu, C. and Chen, S. (2021). Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications. Int. J. Mol. Sci. 22(11):6110.
Zhang, X. and Lerman, L.O. (2017). The metabolic syndrome and chronic kidney disease. Transl. Res. 183:14-25.
Zohara, Z., Adelekun, A., Seffah, K.D., Salib, K., Dardari, L., Taha, M., Dahat, P., Toriola, S., Satnarine, T. and Arcia F.A.P. (2023). The Prospect of Non-Alcoholic Fatty Liver Disease in Adult Patients with Metabolic Syndrome: A Systematic Review. Cureus. 2023 Jul 16;15(7):e41959.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Nigerian Journal of Physiological Sciences